132 related articles for article (PubMed ID: 33130293)
21. Design, Synthesis and Structure-Activity Relationship Studies of Novel 4 (1-adamantyl) Phenyl Analogues as HIF-1α Inhibitors.
Xia Y; Duan Q; Zhao BH; Li DF; Hou RB
Med Chem; 2016; 12(4):338-46. PubMed ID: 26548744
[TBL] [Abstract][Full Text] [Related]
22. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
Xia Y; Jin Y; Kaur N; Choi Y; Lee K
Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationship of (E)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1α inhibitors.
Naik R; Won M; Kim BK; Xia Y; Choi HK; Jin G; Jung Y; Kim HM; Lee K
J Med Chem; 2012 Dec; 55(23):10564-71. PubMed ID: 23153200
[TBL] [Abstract][Full Text] [Related]
24. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
25. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
26. 2,2- dimethylbenzopyran derivatives containing pyridone structural fragments as selective dual-targeting inhibitors of HIF-1α and EZH2 for the treatment of lung cancer.
Xu H; Zhang J; Zhuang J; Chen Y; Chen L; Wang J; Cao R; Liu F; Wang K; Zhang X; Wang L; Chen G
Bioorg Chem; 2024 Jun; 147():107419. PubMed ID: 38703440
[TBL] [Abstract][Full Text] [Related]
27. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis.
Liu M; Liang Y; Zhu Z; Wang J; Cheng X; Cheng J; Xu B; Li R; Liu X; Wang Y
J Med Chem; 2019 Oct; 62(20):9299-9314. PubMed ID: 31556611
[TBL] [Abstract][Full Text] [Related]
29. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.
Koh MY; Spivak-Kroizman T; Venturini S; Welsh S; Williams RR; Kirkpatrick DL; Powis G
Mol Cancer Ther; 2008 Jan; 7(1):90-100. PubMed ID: 18202012
[TBL] [Abstract][Full Text] [Related]
31. Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
Fernandez EV; Reece KM; Ley AM; Troutman SM; Sissung TM; Price DK; Chau CH; Figg WD
Mol Pharmacol; 2015 Jun; 87(6):1006-12. PubMed ID: 25829060
[TBL] [Abstract][Full Text] [Related]
32. Semi-synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol derivatives.
Wang P; Bi XL; Guo YM; Cao JQ; Zhang SJ; Yuan HN; Piao HR; Zhao YQ
Eur J Med Chem; 2012 Sep; 55():137-45. PubMed ID: 22840493
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis and Biological Evaluation of Novel HIF1α Inhibitors.
Masoud GN; Wang J; Chen J; Miller D; Li W
Anticancer Res; 2015 Jul; 35(7):3849-59. PubMed ID: 26124330
[TBL] [Abstract][Full Text] [Related]
34. Requirement of hypoxia-inducible factor-1alpha down-regulation in mediating the antitumor activity of the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
Li X; Lu Y; Liang K; Pan T; Mendelsohn J; Fan Z
Mol Cancer Ther; 2008 May; 7(5):1207-17. PubMed ID: 18483308
[TBL] [Abstract][Full Text] [Related]
35. Discovery of Antimetastatic Chiral Ionone Alkaloid Derivatives Targeting HIF-1α/VEGF/VEGFR2 Pathway.
Liu JJ; Liu XY; Nie JP; Jia MQ; Yu Y; Qin N; Duan HQ
ChemMedChem; 2021 Jul; 16(13):2130-2145. PubMed ID: 33755334
[TBL] [Abstract][Full Text] [Related]
36. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
[TBL] [Abstract][Full Text] [Related]
37. Esterified Derivatives of Panaxadiol and Their Inhibitory Effect on HL-60, THP-1, and PC-3 Cell Lines.
Wang Z; Ding M; Lin Z; He C; Zhao Y
Chem Biodivers; 2019 Aug; 16(8):e1900188. PubMed ID: 31298488
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of 14 and 15-membered macrocyclic scaffolds exhibiting inhibitory activities of hypoxia-inducible factor 1α.
Shimizu T; Takahashi N; Huber VJ; Asawa Y; Ueda H; Yoshimori A; Muramatsu Y; Seimiya H; Kouji H; Nakamura H; Oguri H
Bioorg Med Chem; 2021 Jan; 30():115949. PubMed ID: 33360196
[TBL] [Abstract][Full Text] [Related]
39. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding.
Jones DT; Harris AL
Mol Cancer Ther; 2006 Sep; 5(9):2193-202. PubMed ID: 16985052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]